Mereo BioPharma Group plc
MREO
$2.17
-$0.08-3.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 48.70M | 56.13M | 62.48M | 69.80M | 80.52M |
| Total Receivables | 1.54M | 3.75M | 2.40M | 2.79M | 2.84M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 519.00K | 1.15M | 1.64M | 330.00K | 2.92M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.66M | 402.00K | 380.00K | 1.85M | 437.00K |
| Total Current Assets | 52.41M | 61.42M | 66.90M | 74.76M | 86.72M |
|
|
|||||
| Total Current Assets | 52.41M | 61.42M | 66.90M | 74.76M | 86.72M |
| Net Property, Plant & Equipment | 552.00K | 740.00K | 869.00K | 984.00K | 1.22M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 643.00K | 470.00K | 554.00K | 643.00K | 799.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 53.60M | 62.63M | 68.32M | 76.39M | 88.75M |
|
|
|||||
| Total Accounts Payable | 973.00K | 1.23M | 3.16M | 2.68M | 1.98M |
| Total Accrued Expenses | 4.33M | 5.34M | 3.22M | 4.57M | 5.58M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 397.00K | 601.00K | 747.00K | 6.24M | 6.29M |
| Total Finance Division Other Current Liabilities | 317.00K | 387.00K | 372.00K | 357.00K | 358.00K |
| Total Other Current Liabilities | 317.00K | 387.00K | 372.00K | 357.00K | 358.00K |
| Total Current Liabilities | 6.02M | 7.56M | 7.50M | 13.85M | 14.21M |
|
|
|||||
| Total Current Liabilities | 6.02M | 7.56M | 7.50M | 13.85M | 14.21M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 187.00K | 394.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 988.00K | 897.00K | 744.00K | 1.39M | 1.61M |
| Total Liabilities | 7.00M | 8.45M | 8.24M | 15.42M | 16.21M |
|
|
|||||
| Common Stock & APIC | 551.18M | 549.46M | 547.40M | 542.70M | 539.48M |
| Retained Earnings | -493.67M | -486.64M | -472.03M | -462.88M | -455.84M |
| Treasury Stock & Other | -10.91M | -8.64M | -15.29M | -18.85M | -11.10M |
| Total Common Equity | 46.60M | 54.18M | 60.08M | 60.97M | 72.54M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 46.60M | 54.18M | 60.08M | 60.97M | 72.54M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 46.60M | 54.18M | 60.08M | 60.97M | 72.54M |
|
|
|||||